Attached files
file | filename |
---|---|
EX-13 - EX-13 - UROPLASTY INC | c58445exv13.htm |
EX-31.2 - EX-31.2 - UROPLASTY INC | c58445exv31w2.htm |
EX-21.0 - EX-21.0 - UROPLASTY INC | c58445exv21w0.htm |
EX-32.2 - EX-32.2 - UROPLASTY INC | c58445exv32w2.htm |
EX-23.1 - EX-23.1 - UROPLASTY INC | c58445exv23w1.htm |
EX-31.1 - EX-31.1 - UROPLASTY INC | c58445exv31w1.htm |
EX-24.1 - EX-24.1 - UROPLASTY INC | c58445exv24w1.htm |
10-K - FORM 10-K - UROPLASTY INC | c58445e10vk.htm |
Exhibit 32.1
CERTIFICATION
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Uroplasty, Inc. (the
Company) on
Form 10-K
for the year ended March 31, 2010 as filed with the
Securities and Exchange Commission on the date hereof (the
Report), I, David B. Kaysen, President and
Chief Executive Officer of the Company, certify, pursuant to
18 U.S.C. § 1350, as adopted pursuant to
§ 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of
section 13(a) or 15(d) of the Securities Exchange Act of
1934 and
(2) The information contained in the Report fairly
presents, in all material respects, the financial condition and
result of operations of the Company.
Dated: May 28, 2010
By |
/s/ David
B. Kaysen
|
David B. Kaysen
President and Chief Executive Officer